Xilio Therapeutics Inc
Change company Symbol lookup
Select an option...
XLO Xilio Therapeutics Inc
ORN Orion Group Holdings Inc
SMHI SEACOR Marine Holdings Inc
ASC Ardmore Shipping Corp
CCBC Chino Commercial Bancorp
INGR Ingredion Inc
PROF Profound Medical Corp
VWAGY Volkswagen AG
MLVF Malvern Bancorp Inc
GBCI Glacier Bancorp Inc
Go

Company profile

Xilio Therapeutics, Inc. is a biotechnology company. The Company is focused on harnessing the immune system to achieve clinical responses for cancer patients. It offers a geographically precise solutions (GPS) platform to engineer molecules, including cytokines and other biologics, that are designed to enhance therapeutic index. Using its GPS platform, the Company is engaged in developing a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. Its product candidates include XTX101, XTX202, XTX301, and XTX401. XTX101 is a clinical-stage, tumor-selective anti-cytotoxic T-lymphocyte-associated protein (CTLA-4), monoclonal antibody (mAb), which is designed to improve upon the therapeutic index of existing anti-CTLA-4 therapies. XTX202 and XTX301 are an engineered form of interleukin 2 (IL-2) that is masked with a protein domain to prevent binding activity until the protein domain is cleaved off by tumor microenvironment (TME)-associated proteases.

Closing Price
$2.39
Day's Change
-0.01 (-0.42%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.60
Day's Low
2.17
Volume
(Heavy Day)
Volume:
816,733

10-day average volume:
173,568
816,733

COIN News: Johnson Fistel, Globally-Recognized Law Firm, Encourages Shareholders to Submit Their Coinbase Losses

3:53 pm ET May 11, 2022 (Globe Newswire) Print

EQNX::TICKER_START (NASDAQ:COIN), EQNX::TICKER_END Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Coinbase Global Inc. (NASDAQ: COIN) ("Coinbase" or the "Company"), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focus on investors' losses and whether they may be recovered under the federal securities laws.

What if I purchased Coinbase common stock? If you purchased Coinbase common stock and suffered significant losses on your investment, join our investigation now:

-- Click or paste the following web address into your browser to submit your losses:

https://www.johnsonfistel.com/investigations/coinbase-global-earnings-submit-your-losses

-- Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471

There is no cost or obligation to you.

What is Johnson Fistel investigating? On May 10, 2022, Coinbase reported its first quarter 2022 results. The company stated it lost $430 million in the first quarter. Along with this, the company reported a first-quarter 2022 loss of $1.98 per share compared to the year-ago earnings of $3.05 per share.

What if I have relevant nonpublic information? Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent of any successful recovery made by the SEC. For more information, contact Jim Baker at (619) 814-4471 or jimb@johnsonfistel.com.

About Johnson Fistel, LLP. Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in securities class action and derivative lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:

Johnson Fistel, LLP

Jim Baker, Lead Securities Analyst

Telephone: (619) 814-4471

Email: jimb@johnsonfistel.com

https://ml.globenewswire.com/media/NmI0M2NkNDktNTU2Yi00ZGQ5LThjNDAtODRmNTQ5ZTNiOGM5LTExOTMzNTg=/tiny/Johnson-Fistel-LLP.png

https://ml.globenewswire.com/media/NmI0M2NkNDktNTU2Yi00ZGQ5LThjNDAtODRmNTQ5ZTNiOGM5LTExOTMzNTg=/tiny/Johnson-Fistel-LLP.png

comtex tracking

COMTEX_407055057/2010/2022-05-11T15:53:11

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.